We are live on ! Find out more
ABP

Arthur B. Page Portfolio holdings

AUM $97.2M
1-Year Est. Return 25.76%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+25.76%
3 Year Est. Return
+40.44%
5 Year Est. Return
+103.47%
10 Year Est. Return
+251.6%
AUM
$105M
AUM Growth
+$3.92M
Cap. Flow
-$622K
Cap. Flow %
-0.59%
Top 10 Hldgs %
36.73%
Holding
75
New
5
Increased
34
Reduced
11
Closed
6

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$572K
2
XYL icon
Xylem
XYL
+$273K
3
RTX icon
RTX Corp
RTX
+$265K
4
MA icon
Mastercard
MA
+$232K
5
ABT icon
Abbott
ABT
+$221K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.47M
2
XOM icon
ExxonMobil
XOM
+$1.39M
3
ADP icon
Automatic Data Processing
ADP
+$551K
4
LH icon
Labcorp
LH
+$417K
5
T icon
AT&T
T
+$208K

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Healthcare 20.72%
3 Industrials 18.13%
4 Consumer Staples 11.42%
5 Miscellaneous 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIS icon
51
General Mills
GIS
$19.4B
$336K 0.32%
6,300
PBA icon
52
Pembina Pipeline
PBA
$27.4B
$322K 0.31%
8,830
CL icon
53
Colgate-Palmolive
CL
$69.3B
$320K 0.3%
4,625
SJM icon
54
J.M. Smucker
SJM
$12.8B
$298K 0.28%
2,948
ORCL icon
55
Oracle
ORCL
$414B
$297K 0.28%
6,595
+50
+0.8% +$2.04K
CLX icon
56
Clorox
CLX
$10.7B
$250K 0.24%
2,399
MCK icon
57
McKesson
MCK
$104B
$220K 0.21%
+1,060
New +$215K
TJX icon
58
TJX Companies
TJX
$137B
$218K 0.21%
+6,358
New +$203K
MKC icon
59
McCormick & Company Non-Voting
MKC
$13.5B
$215K 0.2%
+5,800
New +$208K
ABB
60
DELISTED
ABB Ltd
ABB
$205K 0.19%
9,700
-2,100
-18% -$45.4K
VWO icon
61
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$11K 0.01%
263
GSK icon
62
GSK
GSK
$100B
-25,576
Closed -$1.47M
LH icon
63
Labcorp
LH
$25.9B
-4,772
Closed -$417K
T icon
64
AT&T
T
$183B
-7,820
Closed -$208K
TWX
65
DELISTED
Time Warner Inc
TWX
-2,700
Closed -$203K

Similar funds

Arthur B. Page's Q4 2014 Portfolio in Review

As of Q4 2014, Arthur B. Page held 75 positions worth $105M, up 3.9% from $101M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arthur B. Page's Q4 2014 filing shows 5 new, 34 increased, 11 reduced and 6 closed positions. Its largest new stake was CDK Global, Inc.: 16,153 shares worth $659K. The largest sale was GSK, an estimated $1.47M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Arthur B. Page's largest Q4 2014 buy was CDK Global, Inc.: 16,153 shares worth $659K.
  • Arthur B. Page added most to Xylem in Q4 2014, an estimated $273K increase.
  • Arthur B. Page's biggest Q4 2014 reduction was ExxonMobil, cutting an estimated $1.39M.
  • Arthur B. Page fully exited GSK in Q4 2014, selling an estimated $1.47M.
  • Arthur B. Page's ten largest holdings make up 37% of its $105M portfolio in Q4 2014.
  • Arthur B. Page opened 5 new positions and closed 6 in Q4 2014.
  • Arthur B. Page's portfolio value rose 3.9% quarter-over-quarter to $105M.

Based on Arthur B. Page's 13F filing for Q4 2014, filed 13 Feb 2015.